ZYME Zymeworks Inc. - Common Stock
$26.67
가격 · 8월 20, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$14–$30
81% of range
애널리스트 평점
BUY
18 analysts
목표 주가
$40
+51% upside
P/E (TTM)
-24.7
ROE
-26.9%
순이익률
-76.6%
Zymeworks Inc. - Common Stock 정보 위키백과 회사 개요
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
더 보기
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
ZYME 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$26.67
시가총액
$1.99B
P/E (TTM)
-24.7
EPS (TTM)
$-1.08
매출 (TTM)
$106M
배당 수익률
—
ROE
-26.9%
부채/자본
—
52주 범위
$14 – $30
ZYME 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$106M
2020-12-31
→
2025-12-31
EPS
$-1.08
2020-12-31
→
2025-12-31
잉여현금흐름
$-35M
2023-12-31
→
2025-12-31
마진
-76.6%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
ZYME
동종업계 중앙값
P/E (TTM)
-24.7
—
P/S (TTM)
18.8
418.4
P/B
7.4
2.3
Price / FCF (주가 / FCF)
-57.7
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
ZYME
동종업계 중앙값
Operating Margin (영업이익률)
-87.3%
—
Net Profit Margin (순이익률)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
ZYME
동종업계 중앙값
Current Ratio (유동비율)
5.9
12.6
Quick Ratio (당좌 비율)
1.1
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
ZYME
동종업계 중앙값
Revenue YoY (매출 YoY)
38.9%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-36.4%
—
Revenue CAGR 5Y (매출 CAGR 5년)
22.2%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
ZYME
동종업계 중앙값
ZYME 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
18 명의 애널리스트
- 적극 매수 6 33.3%
- 매수 11 61.1%
- 보유 1 5.6%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
12 명의 애널리스트 · 2026-08-16
중앙값
$38.50
← 모든 목표가 하회
$26.67
저가
$31.00
고가
$58.00
중앙값 목표
$38.50
+44.4%
평균 목표
$40.33
+51.2%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.62 | $-0.50 | -0.12% |
| 2026년 3월 31일 | $-0.59 | $-0.20 | -0.39% |
| 2025년 12월 31일 | $-0.55 | $-0.42 | -0.13% |
| 2025년 9월 30일 | $-0.26 | $-0.33 | 0.07% |
| 2025년 6월 30일 | $0.03 | $-0.50 | 0.53% |
| 2025년 3월 31일 | $-0.30 | $-0.42 | 0.12% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
대차대조표 23
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
현금 흐름 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $106M | $76M | $76M | $412M | $27M |
| 영업이익률 % | -87.3% | -179.7% | -181.6% | — | — |
| 순이익 | $-81M | $-123M | $-119M | $124M | $-212M |
| 희석 EPS | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 5.9 | 3.4 | 7.4 | — | — |
| 당좌 비율 | 1.1 | 1.4 | 7.1 | — | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-35M | $-112M | $-121M | — | — |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 218개의 제출자 · $1.5B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 30 (-11 이전 분기 대비) | 30 (-1 이전 분기 대비) | 56 (-17 이전 분기 대비) | 68 (+9 이전 분기 대비) | +200K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600,445,942 | 22,970,388 | 39.27% | 주식 |
| Rubric Capital Management LP | $182,980,000 | 7,000,000 | 11.97% | 주식 |
| PERCEPTIVE ADVISORS LLC | $109,342,391 | 4,182,953 | 7.15% | 주식 |
| BVF INC/IL | $95,388,572 | 3,649,142 | 6.24% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $40,752,208 | 1,558,998 | 2.67% | 주식 |
| Assenagon Asset Management S.A. | $32,727,986 | 1,252,027 | 2.14% | 주식 |
| Nextech Invest Ltd. | $29,118,548 | 1,113,946 | 1.90% | 주식 |
| STATE STREET CORP | $28,445,966 | 1,088,216 | 1.86% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $24,486,776 | 936,755 | 1.60% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23,259,000 | 889,802 | 1.52% | 주식 |
| CITADEL ADVISORS LLC | $21,330,894 | 816,025 | 1.40% | 주식 |
| FMR LLC | $18,355,822 | 702,212 | 1.20% | 주식 |
| Prosight Management, LP | $17,629,705 | 674,434 | 1.15% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $16,322,460 | 624,447 | 1.07% | 주식 |
| Nextech Invest Ltd. | $16,308,169 | 1,113,946 | 1.07% | 주식 |
| Qube Research & Technologies Ltd | $15,516,443 | 593,590 | 1.01% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13,332,236 | 510,032 | 0.87% | 주식 |
| Redmile Group, LLC | $12,851,836 | 491,654 | 0.84% | 주식 |
| Capricorn Fund Managers Ltd | $12,717,868 | 486,529 | 0.83% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10,939,512 | 418,497 | 0.72% | 주식 |
| Hillsdale Investment Management Inc. | $10,009,581 | 382,922 | 0.65% | 주식 |
| GOLDMAN SACHS GROUP INC | $9,345,338 | 357,511 | 0.61% | 주식 |
| FIRST TRUST ADVISORS LP | $8,897,088 | 340,363 | 0.58% | 주식 |
| Granahan Investment Management, LLC | $8,787,144 | 336,157 | 0.57% | 주식 |
| Pictet Asset Management Holding SA | $7,446,189 | 308,187 | 0.49% | 주식 |
| PICTON MAHONEY ASSET MANAGEMENT | $7,092,908 | 271,343 | 0.46% | 주식 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5,849,243 | 223,766 | 0.38% | 주식 |
| SummitTX Capital, L.P. | $5,510,364 | 210,802 | 0.36% | 주식 |
| Man Group plc | $5,509,763 | 210,779 | 0.36% | 주식 |
| BANK OF AMERICA CORP /DE/ | $5,182,437 | 198,257 | 0.34% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $4,066,835 | 155,579 | 0.27% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3,984,154 | 152,416 | 0.26% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3,960,132 | 151,497 | 0.26% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $3,800,390 | 145,386 | 0.25% | 주식 |
| D. E. Shaw & Co., Inc. | $3,785,255 | 144,807 | 0.25% | 주식 |
| DIADEMA PARTNERS LP | $3,715,330 | 142,132 | 0.24% | 주식 |
| BlackRock, Inc. | $3,614,744 | 138,284 | 0.24% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,408,656 | 130,400 | 0.22% | 콜 옵션 |
| CITIGROUP INC | $3,364,872 | 128,725 | 0.22% | 주식 |
| XTX Topco Ltd | $3,290,425 | 125,877 | 0.22% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $3,100,282 | 118,603 | 0.20% | 주식 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2,749,510 | 105,184 | 0.18% | 주식 |
| AXA Investment Managers S.A. | $2,705,745 | 158,416 | 0.18% | 주식 |
| Manatuck Hill Partners, LLC | $2,614,000 | 100,000 | 0.17% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,451,932 | 93,800 | 0.16% | 풋 옵션 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2,321,232 | 88,800 | 0.15% | 주식 |
| MACKENZIE FINANCIAL CORP | $2,293,654 | 87,745 | 0.15% | 주식 |
| VANGUARD GROUP INC | $2,251,979 | 85,529 | 0.15% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $2,181,514 | 83,455 | 0.14% | 주식 |
| LMR Partners LLP | $2,156,550 | 82,500 | 0.14% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $2,127,587 | 81,392 | 0.14% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,094,337 | 80,120 | 0.14% | 주식 |
| TEMA ETFS LLC | $2,000,422 | 75,975 | 0.13% | 주식 |
| RHUMBLINE ADVISERS | $1,962,211 | 75,066 | 0.13% | 주식 |
| Swiss National Bank | $1,939,588 | 74,200 | 0.13% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $1,915,592 | 73,282 | 0.13% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $1,878,786 | 71,874 | 0.12% | 주식 |
| Dana Investment Advisors, Inc. | $1,873,192 | 71,660 | 0.12% | 주식 |
| CREDIT AGRICOLE S A | $1,855,940 | 71,000 | 0.12% | 주식 |
| Fisher Asset Management, LLC | $1,850,057 | 70,775 | 0.12% | 주식 |
| SEGALL BRYANT & HAMILL, LLC | $1,747,093 | 66,836 | 0.11% | 주식 |
| Verdad Advisers, LP | $1,743,224 | 66,688 | 0.11% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $1,705,583 | 65,248 | 0.11% | 주식 |
| Campbell & CO Investment Adviser LLC | $1,591,246 | 60,874 | 0.10% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $1,399,636 | 55,896 | 0.09% | 주식 |
| CITADEL ADVISORS LLC | $1,364,508 | 52,200 | 0.09% | 콜 옵션 |
| Virtus Investment Advisers, LLC | $1,328,566 | 50,825 | 0.09% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $1,272,365 | 48,675 | 0.08% | 주식 |
| Quantinno Capital Management LP | $1,245,362 | 47,642 | 0.08% | 주식 |
| WELLS FARGO & COMPANY/MN | $1,122,164 | 42,929 | 0.07% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $1,111,577 | 42,524 | 0.07% | 주식 |
| Bank of New York Mellon Corp | $1,076,785 | 41,193 | 0.07% | 주식 |
| MARSHALL WACE, LLP | $1,070,380 | 40,948 | 0.07% | 주식 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1,033,419 | 39,534 | 0.07% | 주식 |
| Aquilo Capital Management, LLC | $1,006,181 | 84,482 | 0.07% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965,141 | 36,922 | 0.06% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $953,352 | 36,471 | 0.06% | 주식 |
| HighTower Advisors, LLC | $943,654 | 36,100 | 0.06% | 주식 |
| Persistent Asset Partners Ltd | $939,341 | 35,935 | 0.06% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936,221 | 37,389 | 0.06% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $904,653 | 34,608 | 0.06% | 주식 |
| HighVista Strategies LLC | $889,100 | 34,013 | 0.06% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $837,838 | 32,052 | 0.05% | 주식 |
| TWO SIGMA ADVISERS, LP | $827,157 | 31,415 | 0.05% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807,360 | 30,886 | 0.05% | 주식 |
| SBI Okasan Asset Management Co.Ltd. | $771,200 | 32,000 | 0.05% | 주식 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735,529 | 27,935 | 0.05% | 주식 |
| MetLife Investment Management, LLC | $728,888 | 27,884 | 0.05% | 주식 |
| JOURNEY STRATEGIC WEALTH LLC | $722,304 | 28,846 | 0.05% | 주식 |
| STRS OHIO | $692,710 | 26,500 | 0.05% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $686,933 | 26,279 | 0.04% | 주식 |
| Brevan Howard Capital Management LP | $678,490 | 25,956 | 0.04% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657,735 | 25,162 | 0.04% | 주식 |
| RITHOLTZ WEALTH MANAGEMENT | $633,712 | 24,243 | 0.04% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $607,206 | 23,229 | 0.04% | 주식 |
| Duncan Williams Asset Management, LLC | $577,563 | 22,095 | 0.04% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564,049 | 21,578 | 0.04% | 주식 |
| BARCLAYS PLC | $524,577 | 20,068 | 0.03% | 주식 |
| SIMPLEX TRADING, LLC | $507,926 | 19,431 | 0.03% | 주식 |
| Invesco Ltd. | $491,720 | 18,811 | 0.03% | 주식 |
회사 내부자 28 명의 내부자 · 12 임원 · 17 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 2026년 1월 12일 A | 226,842 | 0 | 4 | $-3,337,929 |
| Kristin Stafford | EVP, Chief Financial Officer | 2026년 4월 6일 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 2024년 1월 5일 A | 6,503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 2023년 3월 10일 M | 17,032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 2026년 7월 6일 A | 133,852 | 0 | 1 | $-138,740 |
| Paul R Schneider | EVP, General Counsel | 2026년 5월 13일 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 2026년 4월 9일 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 2026년 4월 9일 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 2026년 1월 12일 A | 48,497 | 0 | 3 | $-721,486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 2026년 1월 12일 M | 26,708 | 0 | 2 | $-475,562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 2026년 1월 6일 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 2022년 11월 10일 M | 14,449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | 이사 | 2026년 1월 12일 A | 488,500 | 0 | 0 | $0 |
| Alessandra Cesano | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| Carlos Campoy | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| Robert E Landry | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| Kelvin Neu | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| Susan Mahony | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| Brian N Cherry | 이사 | 2026년 1월 12일 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 이사 | 2025년 1월 17일 P | 15,720,161 | 0 | 0 | $0 |
| Nancy Davidson | 이사 | 2024년 12월 10일 A | — | 0 | 0 | $0 |
| Neil Gallagher | 이사 | 2024년 12월 10일 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | 이사 | 2024년 12월 10일 A | — | 0 | 0 | $0 |
| Troy Cox | 이사 | 2024년 12월 10일 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | 이사 | 2023년 12월 7일 A | — | 0 | 0 | $0 |
| Hollings Renton | 이사 | 2023년 12월 7일 A | — | 0 | 0 | $0 |
| Natalie Sacks | 이사 | 2022년 12월 21일 A | — | 0 | 0 | $0 |
| Lota S. Zoth | 이사 | 2022년 12월 21일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 2 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 제출 서류 | 2025년 11월 19일 | 30.70% | 수정본 | 이사회 캠페인 | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 제출 서류 | 2022년 12월 28일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 42 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1.51% | 105,615 NS | 2026년 5월 31일 | N-PORT |
| BBC · ETFis Series Trust I | 0.80% | 10,832 NS | 2026년 4월 30일 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.49% | 186,247 NS | 2026년 4월 30일 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.25% | 110,902 NS | 2026년 4월 30일 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.15% | 16,669 NS | 2026년 5월 31일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.10% | 17,393 NS | 2026년 4월 30일 | N-PORT |
| BIB · ProShares Trust | 0.09% | 2,766 NS | 2026년 5월 31일 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0.09% | 80,480 NS | 2026년 6월 30일 | N-PORT |
| RSSL · Global X Funds | 0.04% | 21,639 NS | 2026년 4월 30일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 189,866 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 2,345 NS | 2026년 5월 31일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 10,887 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.02% | 1,834 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 16,794 NS | 2026년 4월 30일 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1,855 NS | 2026년 5월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 5,236 NS | 2026년 4월 30일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1,925 NS | 2026년 5월 31일 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 26,839 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.01% | 47 NS | 2026년 5월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 5,213 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 72,902 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 12,951 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 8,364 NS | 2026년 4월 30일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 130 NS | 2026년 4월 30일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026년 7월 30일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| IWV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWO · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IBB · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 7월 23일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 2026년 7월 13일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |
| ISCB · iShares Trust | — | — | 2026년 8월 4일 | 일간 |
| ISCG · iShares Trust | — | — | 2026년 8월 4일 | 일간 |
| ISCV · iShares Trust | — | — | 2026년 8월 4일 | 일간 |
| SMMV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| WSML · iShares Trust | — | — | 2026년 8월 4일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 2026년 7월 20일 | 일간 |